PITX2 and atrial fibrillation: Indeed, class IC drugs more effectively prolonged cycle length and reduced phase singularities in PITX2+/− atria (AF termination p = 0.018), suggesting genotype-specific responsiveness that is not currently accounted for in guideline-directed therapy [67].